je.st
news
Pfizer's 3Q beats on emerging market growth
2014-10-28 17:48:20| Biotech - Topix.net
Pfizer reported better-than-expected third quarter earnings Tuesday as higher sales in emerging markets like China helped offset missing revenue from former blockbuster drugs that have lost patent protection. The New York drugmaker reported third-quarter profit of $2.67 billion, or 42 cents per share, up from $2.59 billion, or 39 cents a share, in the prior-year period.
Tags: market
growth
emerging
beats
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||